MiR-424-3p suppresses galectin-3 expression and sensitizes ovarian cancer cells to cisplatin.

Published in: Archives of gynecology and obstetrics (2018)

MiR-424-3p mimic sensitizes SK-OV-3 and TOV-21G ovarian cancer cells to cisplatin by decreasing the expression of galectin-3.

Keyphrases